Hugh Garton

University of Michigan — United States

Medicine · Health Sciences

48h-index10.0kcitations305works0.22yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(147), Cancer, Hypoxia, and Metabolism(105), ATP Synthase and ATPases Research(80), Cerebrospinal fluid and hydrocephalus(60), Spinal Dysraphism and Malformations(47)

Publications304 total

Natural history of pituitary incidentalomas in pediatric patients: a single-center, retrospective analysis

The Journal of Clinical Endocrinology & Metabolism·2026

EXTH-15. Combinatorial targeting of avapritinib-driven MAPK activation in pediatric high-grade glioma

Neuro-Oncology·2025Open Access

TMOD-31. Patient-derived “tumor-oids” recapitulate the tumor microenvironment and allow for pre-clinical drug screening across the entire spectrum of pediatric brain tumors

1 cited

Neuro-Oncology·2025· 1 citedOpen Access

No increased incidence of tethered cord syndrome or low-lying conus in pediatric Chiari malformation type I

Journal of Neurosurgery Pediatrics·2025

Pearls & Oy-sters: Acute Obstructive Hydrocephalus Co-Occurrence With Vigabatrin-Associated MRI Changes in an Infant With LIS1-Related Classical Lissencephaly

1 cited

Neurology·2025· 1 citedOpen Access

Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Cancer Discovery·2025Open Access

Supplementary Figures 1-15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S4 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Supplementary Data S2 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S2 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S11 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S16 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S13 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S1 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S3 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S8 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S6 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S5 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S14 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

Table S15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

2025Open Access

page 1 of 16Next →

Frequent Co-authors

Karin M. Muraszko(25), Cormac O. Maher(22), Jennifer M. Strahle(10), Wajd N. Al‐Holou(8), Carl Koschmann(7), Sriram Venneti(6), Rajen Mody(6), Patricia L. Robertson(6), Richard F. Keep(5), Guohua Xi(5), Paul Park(4), Jason Heth(4), B. Gregory Thompson(4), Sandra Camelo‐Piragua(4), Joseph Kapurch(4), Jayapalli Rajiv Bapuraj(4), Kyle Wierzbicki(4), Amy K. Bruzek(4), Todd Hollon(3), Balaji Pandian(3)